Meet OCRF’s 2016 Grantees
Meet OCRF’s 2016 Grantees
OCRF has awarded $5.2 million in new grants, bringing our total investment in ovarian cancer research to nearly $70 million.
News
OCRF Research Explains Limits of Cancer Immunotherapy Drugs
OCRF Research Explains Limits of Cancer Immunotherapy Drugs
A new study of ovarian cancer cells from the University of Michigan Comprehensive Cancer Center, funded in part by an OCRF grant to Dr. Weiping Zou, reveals molecular changes within the tumor that prevent immunotherapy drugs from killing off the cancer. The research was published in Nature. Immunotherapy treatments have proven wildly successful in treating … Continued
Research Round Up: AACR
Earlier this month, we attended the AACR conference Advances in Ovarian Cancer Research: Exploiting Vulnerabilities, which highlighted many recent pre-clinical advancements in the treatment of ovarian cancer. Much of the work presented was hot off the presses and unpublished – so we were asked not to share too many details from the work publicly. To … Continued
New Ovarian Cancer National Alliance research finds state l...
New Ovarian Cancer National Alliance research finds state lawmakers have power to dramatically improve access to ovarian cancer care and outcomes for the 21,000 women diagnosed each year
For Immediate ReleaseSeptember 23, 2015 New Ovarian Cancer National Alliance research finds state lawmakers have power to dramatically improve access to ovarian cancer care and outcomes for the 21,000 women diagnosed each year WASHINGTON, D.C. — Today, the Ovarian Cancer National Alliance (OCNA) released groundbreaking new data in its report “50 States of Teal: Ovarian … Continued
Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) t...
Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to launch Congressional Ovarian Cancer Caucus at Rally on Tuesday
For Immediate ReleaseSeptember 28, 2015 Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to launch Congressional Ovarian Cancer Caucus at Rally on Tuesday Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to launch Congressional Ovarian Cancer Caucus at Rally on Tuesday WASHINGTON, D.C. — Tomorrow, Representatives Sean Duffy and Rosa DeLauro, who have each been … Continued
#30DaysofTeal Recap
#30DaysofTeal Recap
Missed a day during #30DaysofTeal? Click the plus sign to see everything we did during the month of September!
Precision Medicine Initiative
Precision Medicine Initiative
In January’s State of the Union Address, President Obama ushered in an exciting phase in new medical research by introducing the Precision Medicine Initiative (PMI). This initiative will expand our understanding of personalized medicine, when doctors pick treatments to suit individual patients rather than the ‘one-size-fits-all’ approach. Since January, the President’s advisers have begun to … Continued
BRCA Mutations Confer Risk, Even in Absence of Family History
BRCA Mutations Confer Risk, Even in Absence of Family History
(October 15, 2015) According to a Japanese study published in Cancer, BRCA1/2 gene mutations may be associated with an inherited risk of ovarian cancer regardless of family history. The researchers examined 95 women with ovarian cancer who were treated from 2013 to 2015. BRCA1/2 gene mutation tests were performed with next-generation sequencing in order to determine a link … Continued
Third Party Spotlight
Third Party Spotlight
On December 30-January 1, golfers from across the US will tee off for the Second Annual Joan Kidd MD Ovarian Cancer Awareness Cup at Pebble Beach Golf Links, Pebble Beach, California. The 2016 Awareness Cup will celebrate the life work of Dr. Kidd, who lost her battle to ovarian cancer this summer. Dr. Kidd had a passion for raising ovarian cancer awareness and was a longtime volunteer to Shepherd’s Hope in Central Florida. Click the plus sign to register today.
Most Women Getting BRCA Test not Getting Genetic Counseling
Most Women Getting BRCA Test not Getting Genetic Counseling
(October 7, 2015) A report published in JAMA Oncology shows that most commercially insured women who underwent BRCA genetic testing did not receive genetic counseling by trained genetics professionals. Lack of clinician recommendation was the most commonly reported reason why they didn’t receive genetic counseling. The study authors examined the factors associated with use of … Continued
Partner Member Profile: Lydia's Legacy
When Lydia Greene Ross passed away after a courageous 3-year battle with uterine cancer, her daughter, Carin Ross Johnson, knew something had to be done to make sure that what happened to her mother didn’t happen to anyone else. At the time Lydia was diagnosed, very little awareness and visibility about gynecologic cancer existed. Carin … Continued
Hormone Replacement Therapy Beneficial to Ovarian Cancer Pa...
Hormone Replacement Therapy Beneficial to Ovarian Cancer Patients
(October 1, 2015) A new study published in the Journal of Clinical Oncology shows that women with the most common type of ovarian cancer can safely take hormone replacement therapy (HRT), and it could have a beneficial effect on their survival. The 24-year, phase III international trial provides the strongest evidence yet that women with … Continued